Dr. Tiffany Hood
Senior R&D Scientist, Diagnostics and Genomics, Cytiva
Tiffany Hood is currently a senior R&D scientist at Cytiva in the Diagnostics and Genomics group and is focused on the development of products to enable next-generation diagnostics. Prior to Cytiva, she worked in cell and gene therapy bioprocessing product development. She holds a PhD focused on CAR-T bioprocessing from the University College London (UCL) and a degree in bioengineering from Massachusetts Institute of Technology (MIT).
Latest Content
Webinar
The Future of Diagnostics: Advancements, Challenges and Opportunities
Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clinical areas. But how will this continue to develop in the next five years?
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.
Webinar
The Future of Diagnostics: Advancements, Challenges and Opportunities
Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clinical areas. But how will this continue to develop in the next five years?
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.
Advertisement
